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secreted hormone-like form. Using overexpression and knock-down approaches as well as embry-
onic ﬁbroblasts of knock-out mice we present evidence that Klotho is shedded by the a-secretases
ADAM10 and 17 as well as by the b-secretase b-APP cleaving enzyme 1. The remaining membrane-
bound fragment is a substrate for regulated intramembrane proteolysis by c-secretase. Our data
suggest that therapeutic approaches targeting these proteases should be carefully analyzed for
potential side effects on Klotho-mediated physiological processes.
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Klotho (Kl) is a protein directly linked to aging. Transgenic mice
with an insertion in the Kl locus were found to develop drastic
symptoms of premature aging starting after 3–4 weeks [1]. Symp-
toms included shortened life span, arteriosclerosis, osteoporosis,
skin atrophy and emphysema and resemble human aging. On the
contrary, transgenic mice overexpressing Kl have an extended life
span, suggesting that it has anti-aging properties [2]. Kl is a
120–135 kDa type-I transmembrane protein (for review see [3]).
Interestingly, Kl is shedded and the extracellular part is released
into CSF and serum [4]. Kl is predominantly expressed in the kid-
ney in distal convoluted tubules and in brain in the choroid plexus,
with weaker expression in pituitary, hippocampus, parathyroid
and others [1].
Kl seems to be involved in vitamin D dependent phosphate and
calcium homeostasis [1,5]. It was shown that the transmembranechemical Societies. Published by E
otease; APP, amyloid precur-
tho; MEF, mouse embryonic
ür Altersforschung-Fritz Lip-
y. Fax: +49 3641 656335.
).
k.form of Kl is a co-receptor for FGF-receptor 1, which converts that
receptor into a speciﬁc receptor for FGF23 [6,7].
The anti-aging properties of Kl might be caused by inhibition of
insulin and IGF-1 signaling, since mice lacking Kl are hypoglycemic
and hypersensitive to insulin [8]. This would be in line with
numerous ﬁndings showing the involvement of insulin/IGF-1 sig-
naling pathways in longevity (for review see [3]). Kl overexpress-
ing mice have a higher resistance to oxidative stress [9]. This
resistance might be induced via Kl-mediated downregulation of
insulin/IGF-1 signaling, which is involved in the inactivation of
FOXO transcription factors. Target genes of FOXO transcription fac-
tors are, among others, antioxidant enzymes (for review see [3]).
Type-I transmembrane proteins often are shedded by metallo-
proteases of the ADAM (a disintegrin and metalloprotease) family.
Release of ectodomains by ADAMs can have important physiolog-
ical functions, for example in the case of TNFa or Notch signaling
or the release of soluble Amyloid Precursor Protein (APP) by
ADAM10 and ADAM17 (for review see [10,11]). Shedding can also
be mediated by b-secretase, also called BACE1 (b-APP cleaving en-
zyme 1), a key enzyme in the pathology of Alzheimer’s Disease (for
review see [12]). The remaining membrane-bound fragments
‘‘stubs” are in many instances substrate for a process called regu-
lated intramembrane proteolysis. This process is mediated by an
enzymatic complex called c-secretase for review see [13]. BACE1
and c-secretase are potential drug targets for the treatment
of Alzheimer’s Disease and the latter also for a number oflsevier B.V. All rights reserved.
3222 L. Bloch et al. / FEBS Letters 583 (2009) 3221–3224Notch-driven cancer types. It is therefore important to carefully
study potential substrates of these enzymes and to be aware of po-
tential side effects caused by interfering with their function.
We here show that Kl is processed by ADAM10 and 17 and by
BACE1. The remaining stubs are further processed by c-secretase.ve
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Fig. 1. Kl is shedded by ADAM10 and BACE1. (A) 293Kl cells were transiently
transfected with ADAM10 (A10) or empty vector (vehicle) or with siRNAs as
indicated or treated with PMA or TAPI-1 for 16 h and shedding of Kl was assayed
after 4 h. After Western blotting, lysates and media were probed with Kl antibodies
and relevant lysates with ADAM10 antibodies. (B) mRNA from cells transfected
with transfection reagent only (ctrl) or control siRNAs or two different siRNAs
against ADAM10 was isolated and qPCR using primers speciﬁc for ADAM10 was
performed. mRNA level in ctrl cells was set to 100% and levels in siRNA treated cells
related to that. Results from two independent experiments are shown. (C) 293Kl
cells were transiently transfected with empty vector (vehicle) or with BACE1 cDNA
or with BACE1 cDNA and in addition with siRNAs as indicated or treated with BACE
inhibitor. Thereafter shedding of Kl was assayed as in (A). Lysates in addition were
probed with BACE1 antibodies.2. Material and methods
2.1. Antibodies and cell lines
The following antibodies were used. Anti-ﬂag was purchased
from Sigma–Aldrich; monoclonal anti-GFP from Invitrogen; mono-
clonal anti-Kl (KM2119 from Kyowa Hakko Kogyo Co [14]); poly-
clonal anti-ADAM10 and anti-BACE1 from Abcam. HEK293 cells
stably expressing Presenilin (PS1) and PS1(D385N), respectively,
were described before [15]. mouse embryonic ﬁbroblast (MEF) de-
void of PS1/2 [16], ADAM10, ADAM17, ADAM10/17 and BACE1
[17,18] were described before. 293Kl (HEK293 cells stably express-
ing ﬂag-tagged Kl) were described [6]. Cells were grown in DMEM
supplemented with 10% FCS and Pen/Strep.
2.2. cDNA-constructs and transfections
Flag-tagged Kl was described before [6]. Human cDNA clones
containing the ADAM10 or BACE1 coding region (OpenBiosystems)
were cloned into pcDNA3.1(+) expression vector (Invitrogen).
293Kl and MEF cells were transfected using Lipofectamine 2000
(Invitrogen) and TurboFect (Fermentas), respectively.
2.3. Immunoprecipitation, immunoblotting and shedding assay
For shedding assays cells were plated in 6-well plates and
grown to 70–80% conﬂuency. Twenty-four hours after transfection
with Kl-ﬂag (in case of MEF cells) or 48 h after transfection of siR-
NA or 16 h after drug treatment (in case of HEK293Kl), cells were
washed in PBS and incubated in DMEM without serum for 3–6 h.
The cleared conditioned media were subjected to immunoblot
analysis for Klotho protein directly or after trichloric acid precipi-
tation. Cells were lysed in STEN-lysis buffer (50 mM Tris, pH 7.6,
150 mM NaCl, 2 mM EDTA, 1% NP40 and protease inhibitor mix).
Proteins were separated on 6% SDS–PAGE (for shedding experi-
ments) or 10–20% Tris–Tricine gels (Invitrogen, for c-secretase pro-
cessing), and transferred to PVDF membranes. Membranes were
cut at appropriate positions and blotted with antibodies as indi-
cated. For quantitation, a Fuji LAS4000 Luminescent Image Ana-
lyzer was used. The ratio of cellular versus secreted Kl indicated
shedding efﬁciency.
2.4. Drug treatments
To inhibit c-secretase, cells were incubated overnight with
1 lM DAPT (Axxora) or 5 lM L385,345 (Sigma–Aldrich), respec-
tively. To stimulate or inhibit ADAM mediated shedding, phor-
bol-12-myristate-13-acetate (PMA) was used at 1 lM for 16 h
and TAPI-1 at 25 lM for 16 h, respectively. To inhibit BACE1, C3
(Calbiochem) dissolved in DMSO was used at 2 lM for 16 h.
2.5. siRNA-mediated knock-down
Speciﬁc siRNAs were transfected using Lipofectamine RNAiMAX
(Invitrogen) according to the manufacturer’s protocol and cells and
media were collected 48 h after transfection. For qPCR RNA was
isolated with Trizol reagent (Sigma) 48 h post-transfection and
the PCR was performed with the SYBR Green Master Mix (Applied
Biosystems, Darmstadt, Germany).3. Results
3.1. Kl is processed by ADAM10, 17 and BACE1
Kl is shedded into extracellular ﬂuids similar to APP, suggesting
that a surface protease of the ADAM family or BACE1 might be in-
volved. To get an initial idea if these proteases could cleave Kl,
HEK293 cells stably expressing Kl (HEK293Kl) were ﬁrst subjected
to ADAM10 analysis (Fig. 1A). Activation of ADAMs by PMA in-
creased shedding of Kl by 50%, whereas the metalloprotease inhib-
itor TAPI-1 decreased shedding of Kl by 90%. More speciﬁcally,
overexpression of ADAM10 increased shedding of Kl by 60%
whereas knock-down by two different siRNAs decreased shedding
by 25% and 30%, respectively, suggesting that ADAM10 is involved
in shedding of Kl (Fig. 1A). Efﬁcient knock-down by ADAM10 but
not control siRNAs was veriﬁed on mRNA level (Fig. 1B). Next we
analyzed if BACE1 can mediate shedding of Kl. Overexpression of
BACE1 cDNA but not expression vector alone induced shedding
of Kl (Fig. 1C). Two different BACE1 siRNAs but not control siRNA
decreased BACE1-induced shedding of Kl by 70%. In addition, using
a BACE1 inhibitor, C3, reduced the BACE1-induced shedding of Kl
by 50% (Fig. 1B). Taken together, these data suggest that ADAM10
and BACE1 can shed Kl. Overexpression of an enzyme can only give
hints to its potential role, and knock-down with siRNAs might
cause off-target effects. We therefore made use of mouse
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Fig. 2. Kl is shedded by ADAM10, 17 and BACE1. (A) MEFs cells derived from KO
mice as indicated were transiently transfected with Kl-ﬂag and shedding was
assayed after 24 h. After Western blotting, lysates and media were probed with Kl
antibody. Representative gels are shown. (B) Quantitation of shedding. The ratio of
shedded Kl in the medium versus Kl in cell lysates was determined in all MEF lines.
In ctrl MEF cells this ratio was set to 100% and the ratios from the other cell lines
related to that. Error bars depict standard deviation from 4 to 7 independent
experiments. ***P < 0.001; **P < 0.01.
D
38
5N
Klfl
Klstub6 kDa
130 kDa
w
t
wt
+-
Klfl
Klstub
Kl-flag
6 kDa
+-
PS1/2-/-
130 kDa
L-
68
5,
45
8
Klfl
Klstub
6 kDa
130 kDa
DA
PT
co
n
tro
l
in
pu
t
Klfl
Klstub6 kDa
130 kDa
IP
 fl
ag
IP
 c
trl
Fig. 3. Kl is processed by c-secretase. (A) 293Kl cells were incubated with or
without two different c-secretase inhibitors for 24 h as indicated, lysed and
immunoprecipitated with ﬂag-antibody, separated on 10–20% Tris–Tricine gels,
blotted and probed with ﬂag-antibody. (B) Kl-ﬂag cDNA was transiently transfected
in HEK293 cells stably expressing PS1wt (wt) or dominant-negative PS1(D385N).
Lysates were immunoprecipitated and processed as in (A). (C) MEFs derived from
wild-type mice (wt) or PS1/2 double knock-out mice were transiently transfected
with Kl-ﬂag and processed as in (A). (D) To demonstrate speciﬁcity of the antibody
lysates from HEK293Kl cells were subjected to immunoprecipitation with ﬂag-
antibody (IP ﬂag) and with beads only (IP ctrl) and processed as in (A). In the input
lane 1/25th of the lysate used for IP was loaded.
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respectively. In addition, we tested MEF cells deﬁcient in ADAM17
and deﬁcient in both ADAM10 and 17. Transient transfection of Kl
in these MEF cells showed a strong reduction in shedding in all KO
cells, with some variability between different lines (Fig. 2A, quan-
titation in 2B). A very strong reduction in shedding was observed in
ADAM10/17 double KO MEFs, again supporting the idea that these
two proteases are involved in shedding of Kl. Taken together, these
data indicate that the processing of Kl is similar to APP in that both
a- and b-secretases are able to cleave Kl.
3.2. Kl is processed by c-secretase
The shedding of Kl is reminiscent of APP, Notch and many other
type-I transmembrane proteins. In all these cases the remaining,
membrane-bound stub is substrate for c-secretase. To test if
c-secretase would cleave the Kl stub, we incubated HEK293Kl cells
with or without two different c-secretase inhibitors, L-685,458 and
DAPT (Fig. 3A). In the presence of both inhibitors a small 5 kDa
fragment was observed, which was hardly seen in the absence of
them. To further test if c-secretase is mediating the processing of
the Kl-stub, we transfected Kl-ﬂag in HEK293 cell overexpressing
functional PS1(wt) or non-functional PS1(D385N) [15]. Only in
PS1(D385N) cells without functional c-secretase the 5 kDa frag-
ment was visible, suggesting that it is a substrate of c-secretasewhich is processed in PS1(wt) cells (Fig. 3B). Further evidence for
c-secretase processing of the Kl-stub was provided by transiently
transfecting Kl-ﬂag in mouse embryonic ﬁbroblasts (MEF) derived
from PS1//PS2/ double KO mice and from wild-type mice,
respectively. Fig. 3C demonstrated that the 5 kDa Kl-stub could
be detected only in transfected MEF PS1//PS2/, but not in
transfected wild-type MEF cells, strongly suggesting that the
Kl-stub is substrate for c-secretase (Fig. 3C). The speciﬁcity of the
immunoprecipitation is demonstrated in Fig. 3D. Taken together,
these data show that after shedding of the extracellular domain
Kl is a substrate for intramembrane proteolysis by c-secretase.
4. Discussion
Many of the physiological functions of Kl can be attributed to its
membrane-bound full-length form, for example its role as co-
receptor for FGF23 [6,7]. Its limited expression mainly in the
kidney and choroid plexus together with the occurrence of the se-
creted form of Kl in serum and CSF as well as the plethora of af-
fected tissues in Kl deﬁcient mice suggest a hormone-like role of
the secreted Kl (for review see [3]). One function of the secreted
Kl is to antagonize wnt signaling [19], another the activation of
the calcium channel TRPV5 [20]. It is therefore important to dissect
in molecular detail Kl processing and its regulation that would
inﬂuence the ratio of full length versus secreted form. Here we
show that Kl processing is similar to APP, Notch and other cell sur-
face proteins. Kl can be shedded by ADAM10 and 17. Our data con-
ﬁrm earlier ﬁndings by Chen et al. [21] and extend their ﬁndings by
showing that also BACE1 is able to shed Kl. The ﬁndings presented
here suggest future experiments to study the role of BACE1 in Kl
processing in vivo, since BACE1 inhibitors developed to reduce
amyloid-beta load in Alzheimer’s Disease patients might interfere
with Kl-mediated physiological processes. BACE KO mice do not
have obvious age-related phenotypes, but such phenotypes might
have been overlooked because the potential connection to Kl was
not known. Using inhibitors, dominant-negative PS1 mutations
as well as PS1//PS2/ cells we demonstrate that the Kl-stub
remaining after shedding is substrate for c-secretase. c-Secretase
cleavage might serve to remove the stub from the membrane, as
has been suggested for other substrates [22]. It remains to be
shown whether the intracellular domain, which would be very
3224 L. Bloch et al. / FEBS Letters 583 (2009) 3221–3224small, has a physiological function. Efforts to visualize and purify
this peptide were unsuccessful so far, probably because of its very
low half-life (D.R. and C.K., unpublished). The work presented here
provides the basis for future analysis of the role of shedding in the
physiology of Kl. It will be interesting to investigate if the ratio full-
length/secreted form is changed during aging or under pathophys-
iological conditions and what the underlying mechanisms are.Acknowledgments
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